ICU Medical Inc
ICUINasdaqCIK 883984HealthcareFiscal year ends Dec 31
Reports and events: 280 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-08-0816:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-22-000039 |
| 2022-05-1810:21 ET | 8-K | 5.07 Shareholder vote results | 0000883984-22-000032 |
| 2022-05-0917:15 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000883984-22-000030 |
| 2022-05-0916:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-22-000029 |
| 2022-04-2017:24 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000883984-22-000026 |
| 2022-04-0416:40 ET | DEF 14A | Proxy statementPeriod 2022-04-04 | 0000883984-22-000023 |
| 2022-03-2116:09 ET | 8-K/A | 9.01 Financial statements and exhibits | 0000883984-22-000020 |
| 2022-02-2516:53 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000883984-22-000014 |
| 2022-02-2416:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-22-000012 |
| 2022-02-1808:57 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000883984-22-000009 |
| 2022-02-0109:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000883984-22-000007 |
| 2022-01-1216:30 ET | SC 13D | Ownership report, active investor | 0000950127-22-000003 |
| 2022-01-0708:59 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000883984-22-000005 |
| 2022-01-0416:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000883984-22-000002 |
| 2021-11-0517:01 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000883984-21-000033 |
| 2021-11-0316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-21-000031 |
| 2021-09-2817:03 ET | 8-K | 8.01 Other events | 0000883984-21-000029 |
| 2021-09-0809:08 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-267387 |
| 2021-08-0908:14 ET | 8-K | 8.01 Other events | 0000883984-21-000027 |
| 2021-08-0416:33 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000883984-21-000025 |
| 2021-08-0416:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-21-000024 |
| 2021-07-0716:14 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000883984-21-000020 |
| 2021-05-1413:29 ET | 8-K | 5.07 Shareholder vote results | 0000883984-21-000016 |
| 2021-05-0713:42 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0000883984-21-000014 |
| 2021-05-0616:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-21-000012 |
| 2021-04-0114:44 ET | DEF 14A | Proxy statementPeriod 2021-04-01 | 0000883984-21-000009 |
| 2021-02-2616:59 ET | 10-K | Annual reportPeriod 2020-12-31 | 0000883984-21-000005 |
| 2021-02-2516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-21-000002 |
| 2020-11-0615:27 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0000883984-20-000038 |
| 2020-11-0516:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-20-000037 |
| 2020-08-1016:20 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0000883984-20-000034 |
| 2020-08-1016:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-20-000033 |
| 2020-05-1517:44 ET | 8-K | 5.07 Shareholder vote results | 0000883984-20-000026 |
| 2020-05-0816:03 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0000883984-20-000021 |
| 2020-05-0716:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-20-000019 |
| 2020-04-0312:49 ET | DEF 14A | Proxy statementPeriod 2020-04-03 | 0000883984-20-000016 |
| 2020-03-0208:35 ET | 10-K | Annual reportPeriod 2019-12-31 | 0000883984-20-000014 |
| 2020-02-2816:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000883984-20-000010 |
| 2020-02-2716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-20-000005 |
| 2020-01-0612:41 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000883984-20-000002 |
| 2019-11-1216:38 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0000883984-19-000035 |
| 2019-11-1212:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-19-000031 |
| 2019-08-0915:42 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0000883984-19-000029 |
| 2019-08-0716:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-19-000026 |
| 2019-07-0817:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000883984-19-000024 |
| 2019-05-1612:59 ET | 8-K | 5.07 Shareholder vote results | 0000883984-19-000019 |
| 2019-05-1016:04 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0000883984-19-000017 |
| 2019-05-0916:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-19-000015 |
| 2019-04-0512:02 ET | DEF 14A | Proxy statementPeriod 2019-05-15 | 0000883984-19-000011 |
| 2019-04-0511:43 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000883984-19-000009 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:54 ET. Listed shows no prices and gives no investment advice.